Analysts Set Healthcare Realty Trust Incorporated (NYSE:HR) PT at $21.89

by · The Markets Daily

Healthcare Realty Trust Incorporated (NYSE:HRGet Free Report) has earned an average rating of “Hold” from the eleven ratings firms that are currently covering the stock, MarketBeat Ratings reports. Seven investment analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12 month price objective among brokers that have covered the stock in the last year is $21.70.

A number of brokerages recently weighed in on HR. UBS Group boosted their price objective on shares of Healthcare Realty Trust from $20.00 to $21.00 and gave the stock a “neutral” rating in a report on Wednesday, July 8th. Cantor Fitzgerald increased their target price on Healthcare Realty Trust from $22.00 to $24.00 and gave the company an “overweight” rating in a research note on Friday, July 31st. Weiss Ratings raised Healthcare Realty Trust from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, July 30th. BTIG Research restated a “buy” rating and issued a $22.00 price target on shares of Healthcare Realty Trust in a research note on Friday, June 12th. Finally, Wells Fargo & Company decreased their price target on Healthcare Realty Trust from $21.00 to $20.00 and set an “equal weight” rating for the company in a research note on Tuesday, September 1st.

View Our Latest Stock Report on HR

Insider Transactions at Healthcare Realty Trust

In other Healthcare Realty Trust news, COO Robert E. Hull sold 21,000 shares of Healthcare Realty Trust stock in a transaction that occurred on Tuesday, September 8th. The shares were sold at an average price of $19.11, for a total value of $401,310.00. Following the completion of the sale, the chief operating officer owned 276,338 shares of the company’s stock, valued at approximately $5,280,819.18. The trade was a 7.06% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CAO Amanda L. Callaway sold 25,767 shares of the business’s stock in a transaction on Tuesday, June 23rd. The shares were sold at an average price of $20.37, for a total transaction of $524,873.79. Following the sale, the chief accounting officer owned 109,954 shares of the company’s stock, valued at approximately $2,239,762.98. This represents a 18.99% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.56% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in HR. Cohen & Steers Inc. grew its holdings in Healthcare Realty Trust by 1.3% during the 4th quarter. Cohen & Steers Inc. now owns 56,305,460 shares of the real estate investment trust’s stock valued at $954,424,000 after buying an additional 744,729 shares in the last quarter. Resolution Capital Ltd raised its holdings in shares of Healthcare Realty Trust by 72.4% during the 1st quarter. Resolution Capital Ltd now owns 14,034,367 shares of the real estate investment trust’s stock worth $238,444,000 after acquiring an additional 5,892,501 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Healthcare Realty Trust by 1.5% during the 4th quarter. Geode Capital Management LLC now owns 7,053,360 shares of the real estate investment trust’s stock valued at $119,578,000 after acquiring an additional 101,382 shares during the last quarter. PGGM Investments bought a new position in shares of Healthcare Realty Trust during the 4th quarter valued at approximately $113,389,000. Finally, Centersquare Investment Management LLC grew its holdings in shares of Healthcare Realty Trust by 38.0% in the fourth quarter. Centersquare Investment Management LLC now owns 5,970,456 shares of the real estate investment trust’s stock valued at $101,199,000 after purchasing an additional 1,645,208 shares in the last quarter.

Healthcare Realty Trust Stock Performance

NYSE:HR opened at $18.25 on Tuesday. The firm has a market cap of $6.25 billion, a P/E ratio of -70.17 and a beta of 0.95. Healthcare Realty Trust has a fifty-two week low of $16.31 and a fifty-two week high of $22.04. The firm has a 50-day simple moving average of $19.87 and a two-hundred day simple moving average of $19.40.

Healthcare Realty Trust (NYSE:HRGet Free Report) last issued its earnings results on Thursday, July 30th. The real estate investment trust reported ($0.13) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.40 by ($0.53). The firm had revenue of $278.58 million during the quarter, compared to analysts’ expectations of $271.60 million. Healthcare Realty Trust had a negative return on equity of 1.91% and a negative net margin of 7.59%.The firm’s quarterly revenue was down 5.3% on a year-over-year basis. During the same period last year, the firm posted $0.41 earnings per share. Healthcare Realty Trust has set its FY 2026 guidance at 1.620-1.660 EPS. On average, equities research analysts predict that Healthcare Realty Trust will post 1.65 EPS for the current year.

Healthcare Realty Trust Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, August 26th. Investors of record on Tuesday, August 11th were issued a $0.24 dividend. This represents a $0.96 annualized dividend and a yield of 5.3%. The ex-dividend date was Tuesday, August 11th. Healthcare Realty Trust’s dividend payout ratio (DPR) is presently -369.23%.

About Healthcare Realty Trust

(Get Free Report)

Healthcare Realty Trust Incorporated is a real estate investment trust focused on owning, developing, acquiring, leasing and managing outpatient healthcare properties. Its portfolio primarily includes medical office buildings and other facilities that support outpatient care, such as ambulatory care centers and healthcare campuses.

The company serves healthcare providers across the United States, with properties generally located near hospitals and in major and growing markets. Its customers include health systems, physician groups and other healthcare providers.

Featured Stories